SCHEMBL24005106

SCHEMBL24005106

CC(C)(C)c1ccc(Nc2csc3ccccc23)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PKM P14618 1/20 0.46
▸ MAPT P10636 6/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ ABCG2 Q9UNQ0 1/20 0.42
▸ CCR4 P51679 2/20 0.41
▸ PMM2 O15305 1/20 0.39
▸ MPI P34949 1/20 0.39
▸ PHOSPHO1 Q8TCT1 1/20 0.39
▸ EPHX2 P34913 1/20 0.38
▸ KDR P35968 4/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ PDGFRB P09619 1/20 0.38
▸ KIT P10721 1/20 0.38
▸ FLT1 P17948 1/20 0.38
▸ AKR1C3 P42330 2/20 0.36
▸ AKR1C2 P52895 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23444395 0.86 KDM4E (0.44) MAPTRAB9ANPC1ABCG2CCR4
SCHEMBL30679848 0.82 ABCG2 (0.41) ABCG2CCR4KDRAKR1C3AKR1C2
SCHEMBL28703910 0.82 ABCG2 (0.41) ABCG2CCR4KDRAKR1C3AKR1C2
SCHEMBL24509376 0.82 PKM (0.50) PKMMAPTRAB9ANPC1GAA
SCHEMBL29292676 0.82 KDM4E (0.41) MAPTABCG2CCR4AKR1C3AKR1C2
SCHEMBL29985567 0.81 NR3C2 (0.40) PKMMAPTRAB9ANPC1GAA
SCHEMBL17740783 0.81 MAPT (0.60) PKMMAPTRAB9ANPC1GAA
SCHEMBL25104186 0.81 KDM4E (0.38) MAPTRAB9ANPC1ABCG2CCR4
SCHEMBL25952526 0.81 L3MBTL1 (0.41) MAPTCCR4AKR1C3AKR1C2
SCHEMBL21307820 0.79 MAPT (0.46) PKMMAPTRAB9ANPC1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11685751-B2 Compound and organic light-emitting element comprising same LG CHEM, LTD. (KR) 2023-06-27 — — US disclosed
CN-116253749-A Compound and application thereof, and organic electroluminescent device comprising compound 北京鼎材科技有限公司 2023-06-13 — — CN disclosed
US-20230137925-A1 HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND IDEMITSU KOSAN CO.,LTD (JP) 2023-05-04 — — US disclosed
US-20230137925-A1 HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND IDEMITSU KOSAN CO.,LTD (JP) 2023-05-04 — — US disclosed
US-20230061019-A1 COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2023-03-02 — — US disclosed
WO-2022139525-A1 ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC COMPOUND 주식회사 엘지화학 2022-06-30 — — WO disclosed
WO-2021255698-A1 HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2021-12-23 — — WO disclosed
EP-3907228-A1 COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME LG Chem, Ltd. (KR) 2021-11-10 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230061019-A1 COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, LEF1 PKM 3121/4885MAPT 528/4885RAB9A 2937/4885
US-20230137925-A1 HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND DDT, DDC, ODC1 PKM 1213/4885MAPT 1595/4885RAB9A 2282/4885
US-11685751-B2 Compound and organic light-emitting element comprising same CRY1, CRY2, LEF1 PKM 3121/4885MAPT 528/4885RAB9A 2937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback